Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1202845019 | Levothyroxine sodium + liothyronine sodium 25mcg/6.25mcg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1207771016 | Laevothyroxine sodium + liothyronine sodium 25mcg/6.25mcg tablet | en | Synonym (core metadata concept) | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1208582013 | Levothyroxine sodium + liothyronine sodium 25mcg/6.25mcg tablet | en | Synonym (core metadata concept) | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1475937010 | Laevothyroxine sodium+liothyronine sodium 25mcg/6.25mcg tablet | en | Synonym (core metadata concept) | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1476898013 | Levothyroxine sodium+liothyronine sodium 25mcg/6.25mcg tablet | en | Synonym (core metadata concept) | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3468105013 | Levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3468106014 | Product containing levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3486158017 | Product containing levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3569429011 | Product containing only levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3569430018 | Product containing only levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3680191010 | Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3680192015 | Levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3680193013 | Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Liothyronine sodium preparation | false | Inferred relationship | Some | ||
| Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Liothyronine sodium | false | Inferred relationship | Some | ||
| Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Liothyronine | false | Inferred relationship | Some | ||
| Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing levothyroxine sodium | false | Inferred relationship | Some | ||
| Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Levothyroxine sodium | false | Inferred relationship | Some | ||
| Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing levothyroxine sodium and liothyronine sodium | false | Inferred relationship | Some | ||
| Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
| Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Oral tablet | true | Inferred relationship | Some | ||
| Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Liothyronine-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing levothyroxine sodium in oral dosage form | false | Inferred relationship | Some | ||
| Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | mcg | true | Inferred relationship | Some | 1 | |
| Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
| Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | mcg | true | Inferred relationship | Some | 2 | |
| Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 2 | |
| Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
| Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Liothyronine sodium | false | Inferred relationship | Some | 1 | |
| Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Liothyronine sodium | false | Inferred relationship | Some | 1 | |
| Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 6.25 | false | Inferred relationship | Some | 1 | |
| Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Levothyroxine sodium | false | Inferred relationship | Some | 2 | |
| Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Levothyroxine sodium | false | Inferred relationship | Some | 2 | |
| Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 25 | false | Inferred relationship | Some | 2 | |
| Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Liothyronine sodium | false | Inferred relationship | Some | 1 | |
| Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Levothyroxine sodium | false | Inferred relationship | Some | 2 | |
| Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Levothyroxine- and liothyronine-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | deux | false | Inferred relationship | Some | ||
| Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Levothyroxine and liothyronine only product in oral dose form | true | Inferred relationship | Some | ||
| Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Liothyronine sodium | true | Inferred relationship | Some | 2 | |
| Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Levothyroxine sodium | true | Inferred relationship | Some | 1 | |
| Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Levothyroxine sodium | true | Inferred relationship | Some | 1 | |
| Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Liothyronine sodium | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR